What Happens to Anxiety Levels on Giving Up Smoking?
Overview
Affiliations
Objective: DSM-IV lists increased anxiety as a nicotine withdrawal symptom. Increased anxiety has been reported to follow smoking cessation in most but not all studies. Indeed, there is some evidence for a reduction in anxiety, compared with precessation levels, after the first few weeks of abstinence. This study reports data from 101 smokers who attempted to stop smoking and who satisfied DSM-III-R criteria for nicotine dependence.
Method: Unlike most studies in this area, a strict criterion of lapse-free abstinence was adopted. It is argued that lapses during an attempt at cessation may underlie a transient increase in anxiety. Anxiety was measured both by a single rating typical in withdrawal studies and by the State-Trait Anxiety Inventory--State Form X. Patients were rated 2 weeks and 1 week before cessation, immediately before cessation, 24 hours after cessation, and 1, 2, 3, and 4 weeks after cessation.
Results: Seventy patients were abstinent for the 4-week follow-up period. There was no evidence of an increase in anxiety following smoking cessation. However, there was a significant decrease in anxiety from the first week of abstinence.
Conclusions: The results weaken the view that increased anxiety is a robust and central element of the nicotine withdrawal syndrome and suggest that giving up smoking is quite rapidly followed by a reduction in anxiety that may reflect removal of an anxiogenic agent, nicotine.
Du X, Choa F, Chiappelli J, Bruce H, Kvarta M, Summerfelt A Brain Stimul. 2024; 17(2):324-332.
PMID: 38453003 PMC: 11445730. DOI: 10.1016/j.brs.2024.02.020.
Almeida R, Barbosa C, Pereira B, Diniz M, Baena A, Conde A Int J Environ Res Public Health. 2022; 19(11).
PMID: 35682178 PMC: 9180849. DOI: 10.3390/ijerph19116595.
Fatani B, Al-Yahyawi H, Raggam A, Al-Ahdal M, Alzyoud S, Hassan A Health Sci Rep. 2022; 5(2):e503.
PMID: 35229052 PMC: 8867423. DOI: 10.1002/hsr2.503.
Manwell L, Miladinovic T, Raaphorst E, Rana S, Malecki S, Mallet P Brain Behav. 2019; 9(11):e01375.
PMID: 31583843 PMC: 6851810. DOI: 10.1002/brb3.1375.
Benzodiazepines I: Upping the Care on Downers: The Evidence of Risks, Benefits and Alternatives.
Guina J, Merrill B J Clin Med. 2018; 7(2).
PMID: 29385731 PMC: 5852433. DOI: 10.3390/jcm7020017.